Prevention of Fascial Dehiscence With Prophylactic Onlay Mesh in Emergency Laparotomies
NCT ID: NCT03293862
Last Updated: 2019-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
145 participants
INTERVENTIONAL
2015-06-30
2018-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimal Method of Fascial Closure in High Risk Patients Undergoing Laparotomy
NCT02145052
Prophylactic Application of an Incisional Wound Vac to Prevent Wound Complications in Obese Spine Surgery Patients
NCT02926924
Use of Hypertonic Saline After Damage Control Laparotomy to Improve Early Primary Fascial Closure
NCT02297659
Prophylactic Negative Pressure Dressings for Closed Laparotomy Wounds - A Randomised, Controlled, Open Label Trial
NCT02780453
Prevention of Incisional Hernia With Biosynthetic Mesh at the Site of Temporary Ileostomy Closure (PRINCESS)
NCT05400083
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Suture group
Patients randomized to this arm will undergo midline laparotomy closure using a PDS 0 continuous suture only, without mesh, aiming a suture length to wound length ratio higher than four. Randomization occurs after fascial closure.
Midline Fascial Closure
midline fascial closure using uninterrupted PDS 0 suture
Prophylactic mesh group
Patients randomized to this arm will undergo midline laparotomy closure using a PDS 0 continuous suture aiming a suture length to wound length ratio higher than four AND further polypropilene onlay mesh. Randomization occurs after fascial closure.
prophylactic polypropilene mesh
Placement of onlay polypropilene prophylactic mesh after midline fascial closure.
Midline Fascial Closure
midline fascial closure using uninterrupted PDS 0 suture
vacuum drainage system
Placement of a subcutaneous vacuum drainage system
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
prophylactic polypropilene mesh
Placement of onlay polypropilene prophylactic mesh after midline fascial closure.
Midline Fascial Closure
midline fascial closure using uninterrupted PDS 0 suture
vacuum drainage system
Placement of a subcutaneous vacuum drainage system
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* High risk for abdominal wound dehiscence: Risk index\*\* ≥ 4,0 or ≥ 2,2 in combination with at least one of the following: smoking, obesity, malnutrition or malignant neoplasia.
* Risk index is the sum of values associated with high-risk characteristics, based in the risk score for abdominal wall dehiscence published by van Ramshorst et. al. in World Journal of Surgery, 2010 (Rotterdam risk model):
Age category (in years)
* 40-49: 0.4
* 50-59: 0.9
* 60-69: 0.9
* ≥70: 1.1
Male gender: 0.7
Chronic pulmonary disease: 0.7
Ascites: 1.5
Jaundice: 0.5
Anemia: 0.7
Emergency surgery: 0.6
Type of surgery:
* Gallbladder/bile duct 0.7
* Esophagus 1.5
* Gastroduodenum 1.4
* Small bowel 0.9
* Large bowel 1.4
* Vascular 1.3
Exclusion Criteria
* Diagnosis of incisional hernia or presence of previous mesh on site.
* Midline laparotomy performed in less than 30 days.
* Pregnancy
* Severe trauma with hemodynamic instability
* Need for open abdomen or relaxing incisions
* Need for re-laparotomy during the first 30 postoperative days, except cases in which an abdominal wall dehiscence was diagnosed.
* Death during the first 30 postoperative days, except cases in which an abdominal wall dehiscence was diagnosed before the event.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Edivaldo Massazo Utiyama
MD, PhD, Full Professor of Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
São Paulo, São, Brazil
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gomez Diaz CJ, Rebasa Cladera P, Navarro Soto S, Hidalgo Rosas JM, Luna Aufroy A, Montmany Vioque S, Corredera Cantarin C. [Validation of abdominal wound dehiscence's risk model]. Cir Esp. 2014 Feb;92(2):114-9. doi: 10.1016/j.ciresp.2012.12.008. Epub 2013 May 3. Spanish.
van Ramshorst GH, Nieuwenhuizen J, Hop WC, Arends P, Boom J, Jeekel J, Lange JF. Abdominal wound dehiscence in adults: development and validation of a risk model. World J Surg. 2010 Jan;34(1):20-7. doi: 10.1007/s00268-009-0277-y.
Lima HVG, Rasslan R, Novo FCF, Lima TMA, Damous SHB, Bernini CO, Montero EFS, Utiyama EM. Prevention of Fascial Dehiscence with Onlay Prophylactic Mesh in Emergency Laparotomy: A Randomized Clinical Trial. J Am Coll Surg. 2020 Jan;230(1):76-87. doi: 10.1016/j.jamcollsurg.2019.09.010. Epub 2019 Oct 28.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024878
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.